An individual’s body mass index (BMI) can increase when exposed to counties with a higher prevalence of obesity, according to a study published in JAMA Pediatrics.
An individual’s body mass index (BMI) can increase when exposed to counties with a higher prevalence of obesity, according to a study published in JAMA Pediatrics.
Certain areas in the United States have been associated with higher levels of overweight and obesity in adults and children. In the past, researchers have considered weight gain to be a social contagion—as more people become overweight or obese in a community, the likelihood of other people gaining weight in the same environment increases. If overweight/obesity in individuals is, in fact, a social contagion, then public health policy can easily intervene within communities to promote healthy eating and exercise.
The researchers sought to find out if exposure to communities with higher rates of overweight and obese members would increase the BMI of individual residents. In order to eliminate the role self-selection plays in choosing an area to life, military families were chosen as the best participants for the study since the government assigns the location of residency. The study included 38 installations across 35 counties.
The study used already collected data from the Military Teenagers’ Environments, Exercise, and Nutrition Study. The adult obesity rate in the military member’s assigned county was used to measure exposure.
From the 1519 participating families, 1 parent and 1 child were included in the study from November 2016 to October 2017. The outcomes for adults were BMI, overweight/obesity (BMI, > 25) and obesity (BMI, > 30). BMI z score, overweight/obesity (BMI percentile for age and sex, > 85), and obesity (BMI percentile for age and sex, > 95) were measured outcomes for children.
Self-reports from parents and children recording height and weight determined the outcomes for the participants. A total of 1314 adults and 1111 children were included in the study.
The data show that a 1% higher county obesity rate was associated with a higher BMI and increased chance of obesity in parents. In children, a higher BMI z score and greater odds of overweight/obesity were also associated with a higher county obesity rate.
Limitations acknowledged by the authors included the focus on geography and not the network-based interactions associated with weight gain and the BMI self-reports from parents that could be miscalculated.
“Exposure to counties with a higher prevalence of obesity was associated with higher BMI, overweight, and/or obesity in parents and children,” the authors concluded. “There was no evidence to support self-selection or shared environment as explanations for this association, which may suggest the presence of social contagion in obesity.”
References
Datar A, Nicosia N. Association of exposure to communities with higher ratios of obesity with increased body mass index and risk of overweight and obesity among parents and children. [published online January 22, 2018]. JAMA Pediatr. doi: 10.1001/jamapediatrics.2017.4882.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
September 20th 2024The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for patients, prompting renewed calls for PBM reform.
Read More
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
September 5th 2024This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Read More